Therapy News and Research

RSS

Diabetes management accepted for coverage by Chemical Abstracts

Future Medicine Ltd announces today that its new journal Diabetes Management (ISSN 1758-1907) which launched in January 2011 has been selected for coverage by Chemical Abstracts.

24 Mar 2011

JWOCN joins with CAET to expand its position within global community of nursing

The Journal of Wound, Ostomy and Continence Nursing has affiliated with the Canadian Association for Enterostomal Therapy, expanding its position within the global community of wound, ostomy and continence nursing.

24 Mar 2011

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Amgen today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.

24 Mar 2011

Molecular Therapy journal publishes Mirna's new tumor suppressor miRNA mimics data

Mirna Therapeutics, Inc. announced today the publication of new results in the journal Molecular Therapy demonstrating how a neutral lipid emulsion facilitates the systemic delivery of tumor suppressor miRNA mimics and reduces the tumor burden in the lungs of mice.

24 Mar 2011

Resveratrol can provide resistance before and after hazardous radiation exposure

Clinical studies of Resveratrol--recognized for its proven role in activating the longevity gene to inhibit age-related diseases--have shown that its antioxidant power provides resistance before and after exposure to hazardous radiation.

24 Mar 2011

Sequencing mouse cancer genome reveals mutations driving cancer in humans

Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.

24 Mar 2011

Brain's pleasure and reward circuitry gets a big boost after a sleepless night

A sleepless night can make us cranky and moody. But a lesser known side effect of sleep deprivation is short-term euphoria, which can potentially lead to poor judgment and addictive behavior, according to new research from the University of California, Berkeley.

24 Mar 2011

Statins improve outcomes in high-risk prostate cancer patients treated with definitive radiation therapy

Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a study published in the March issue of the International Journal of Radiation Oncology-Biology-Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

24 Mar 2011

Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.

24 Mar 2011

John Muir Health provides new cancer treatment using Varian's RapidArc radiation therapy

John Muir Health is offering a new cancer treatment option using the latest technology from Varian Medical Systems - The Trilogy Linear Accelerator with RapidArc Technology. The new accelerator, located at John Muir Medical Center, Concord, significantly shortens treatment sessions from 15-20 minutes to 2-5 minutes, while improving the precision of the radiotherapy.

24 Mar 2011

Opexa's Tovaxin data against MS to be presented at AAN Annual Meeting

Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis, announced today that the Company has been selected to present key Tovaxin data at the upcoming American Academy of Neurology 63rd Annual Meeting to be held in Honolulu, Hawaii April 9-16, 2011.

24 Mar 2011

Gut bacteria and state of immune system influence personality

Researchers at McMaster University discovered that the "cross-talk" between bacteria in our gut and our brain plays an important role in the development of psychiatric illness, intestinal diseases and probably other health problems as well including obesity.

24 Mar 2011

Rapid treatment within an hour of injury dramatically cuts bleeding deaths in injured patients

An hour can make the difference between life and death when using tranexamic acid to treat injured patients with severe bleeding, a study by researchers at the London School of Hygiene & Tropical Medicine suggests.

24 Mar 2011

MicroRNAs may play a key role in future medicine

Since their discovery in the 1990s, microRNAs have proven to play a complex role in normal and abnormal functioning of many organ systems. In the April issue of Translational Research, entitled "MicroRNAs: A Potential New Frontier for Medicine," an international group of medical experts explores several themes related to our current understanding of microRNAs and the role they may play in the future of medicine.

24 Mar 2011

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

23 Mar 2011

NephRx receives new U.S. patent for NX002 to treat oral mucositis

NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

23 Mar 2011

FDA approves Nordion's TheraSphere IDE for Phase III trial to treat HCC

Nordion Inc., a leading provider of products and services to the global health science market, today announced that it has received U.S. Food and Drug Administration approval to conduct a Phase III clinical trial for TheraSphere® under an Investigational Device Exemption.

23 Mar 2011

GoodTherapy.org launches new syndicated advice-column for psychotherapy problems

GoodTherapy.org recently launched its new, syndicated bi-weekly column "Dear GoodTherapy.org"; aimed at answering real questions for real peoples' problems about psychotherapy, marriage counseling and mental health issues.

23 Mar 2011

Toddlers who played with fewer toys show improvement in communication skills

Toddlers who played with a limited number of toys showed more improvement in their communication skills following parent-guided treatment than those receiving other community-based treatments.

23 Mar 2011

MnSOD oral drug can protect against lung cancer radiation therapy

Patients with advanced non-small cell lung cancer can safely take an experimental oral drug intended to protect healthy tissue from the effects of radiation, according to a study led by researchers at the University of Pittsburgh Cancer Institute and published in this month's issue of Human Gene Therapy.

23 Mar 2011

Therapy News and Research

Diabetes management accepted for coverage by Chemical Abstracts

JWOCN joins with CAET to expand its position within global community of nursing

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Molecular Therapy journal publishes Mirna's new tumor suppressor miRNA mimics data

Resveratrol can provide resistance before and after hazardous radiation exposure

Sequencing mouse cancer genome reveals mutations driving cancer in humans

Brain's pleasure and reward circuitry gets a big boost after a sleepless night

Statins improve outcomes in high-risk prostate cancer patients treated with definitive radiation therapy

Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment

John Muir Health provides new cancer treatment using Varian's RapidArc radiation therapy

Opexa's Tovaxin data against MS to be presented at AAN Annual Meeting

Gut bacteria and state of immune system influence personality

Rapid treatment within an hour of injury dramatically cuts bleeding deaths in injured patients

MicroRNAs may play a key role in future medicine

Cilag, POZEN enter license agreement to develop and commercialize MT 400

NephRx receives new U.S. patent for NX002 to treat oral mucositis

FDA approves Nordion's TheraSphere IDE for Phase III trial to treat HCC

GoodTherapy.org launches new syndicated advice-column for psychotherapy problems

Toddlers who played with fewer toys show improvement in communication skills

MnSOD oral drug can protect against lung cancer radiation therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News